MGRN1 and ovarian serous adenocarcinoma: To investigate the role of MGRN1 expression in the sensitivity of serous ovarian cancer cells to cisplatin, SKOV3 cells were transfected with shRNAa-MGRN1, shRNAb-MGRN1, shRNAc-MGRN1 plasmid or shNC plasmid, respectively.